Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
CCL16/HCC-4/LEC Antibody (LEC66), Novus Biologicals™

Mouse Monoclonal Antibody
$510.00
Specifications
| Antigen | CCL16/HCC-4/LEC |
|---|---|
| Clone | LEC66 |
| Dilution | ELISA, Functional, SDS-Page |
| Applications | ELISA, Functional Assay, SDS-Page |
| Classification | Monoclonal |
| Catalog Number | Mfr. No. | Quantity | Price | Quantity & Availability | |||||
|---|---|---|---|---|---|---|---|---|---|
| Catalog Number | Mfr. No. | Quantity | Price | Quantity & Availability | |||||
NBP232857A
![]() |
Novus Biologicals
NBP2328570.1MG |
0.1 mg |
Each for $510.00
|
|
|||||
NBP232857B
![]() |
Novus Biologicals
NBP2328570.2MG |
0.2 mg | N/A | N/A | N/A | ||||
Description
CCL16/HCC-4/LEC Monoclonal specifically detects CCL16/HCC-4/LEC in Human samples. It is validated for ELISA.Specifications
| CCL16/HCC-4/LEC | |
| ELISA, Functional, SDS-Page | |
| Monoclonal | |
| Purified | |
| RUO | |
| PBS with 0.05% BSA. with 0.05% Sodium Azide | |
| C-C motif chemokine 16, chemokine (C-C motif) ligand 16, Chemokine CC-4, Chemokine LEC, CKb12, HCC-4Liver-expressed chemokine, LCC-1Lymphocyte and monocyte chemoattractant, LEC, liver CC chemokine-1, LMCSmall-inducible cytokine A16, monotactin-1, MTN-1, NCC4IL-10-inducible chemokine, NCC-4ILINCK, new CC chemokine 4, SCYA16MGC117051, SCYL4, small inducible cytokine subfamily A (Cys-Cys), member 16 | |
| CCL16 | |
| IgG1 κ | |
| Protein A purified | |
| Shows chemotactic activity for lymphocytes and monocytes but not neutrophils. Also shows potent myelo-suppressive activity, suppresses proliferation of myeloid progenitor cells. Recombinant SCYA16 shows chemotactic activity for monocytes and THP-1 monocytes, but not for resting lymphocytes and neutrophils. Induces a calcium flux in THP-1 cells that were desensitized by prior expression to RANTES. Mainly expressed in liver, also found in spleen and thymus. Highly expressed in LPS- and IFN-gamma-activated monocytes, weakly in some lymphocytes, including natural killer cells, gamma-delta T-cells, and some T-cell clones. The ability of HCC-4 to markedly improve recognition of poorly immunogenic cells suggests that it could be an effective component of antitumor vaccines. |
| LEC66 | |
| ELISA, Functional Assay, SDS-Page | |
| Unconjugated | |
| Mouse | |
| Human | |
| O15467 | |
| 6360 | |
| Recombinant human HCC-4 protein | |
| Primary | |
| Store at 4C. | |
| 11 kDa |
Spot an opportunity for improvement?Share a Content Correction
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title